Skip to main content

Growth Hormone Secretagogue Liability

Meaning

Growth Hormone Secretagogue Liability denotes the potential legal and financial risks associated with the prescribing, compounding, or administering of agents that stimulate the release of growth hormone. This liability arises primarily from the ambiguous regulatory status of many growth hormone secretagogues or GHSs, which are often not approved by the Food and Drug Administration or FDA for anti-aging or general wellness indications. The risk profile includes potential for adverse patient outcomes, regulatory enforcement actions, and professional malpractice claims related to off-label use. Clinicians must navigate this complex regulatory landscape with extreme caution.